cipaglucosidase alfa-atga 105 MG Injection
- RxCUI
- 2667440
- RxNorm name
- cipaglucosidase alfa-atga 105 MG Injection
- Display name
- cipaglucosidase alfa-atga 105 MG Injection
- Full name
- cipaglucosidase alfa-atga 105 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761204 | Pombiliti | cipaglucosidase alfa-atga | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POMBILITI ATGA | CIPAGLUCOSIDASE ALFA-ATGA | AMICUS THERAPEUTICS US, LLC | d77aa596-910d-516b-e053-2995a90a0839 | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 2667440 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d77aa596-910d-516b-e053-2995a90a0839 | cipaglucosidase alfa-atga 105 MG Injection | PSN | 5 | These highlights do not include all the information needed to use POMBILITI ® safely and effectively. See full prescribing information for POMBILITI. POMBILITI (cipaglucosidase alfa-atga) for injection, for intravenous use Initial U.S. Approval: 2023 | 20241127 |
| d77aa596-910d-516b-e053-2995a90a0839 | cipaglucosidase alfa-atga 105 MG Injection | SCD | 5 | These highlights do not include all the information needed to use POMBILITI ® safely and effectively. See full prescribing information for POMBILITI. POMBILITI (cipaglucosidase alfa-atga) for injection, for intravenous use Initial U.S. Approval: 2023 | 20241127 |